BPC-157 doses in research typically range from 200 to 800 mcg per day, given once or twice daily by subcutaneous injection or oral capsule. Animal studies most often use 10 mcg/kg of body weight as a reference. There is no standardized human protocol, so a physician should set your dose based on your condition, body weight, route, and goals. This page is educational. BPC-157 is not FDA-approved
Quick answer: What is the standard BPC-157 dose? Research uses 200 to 800 mcg per day, with 10 mcg/kg as the common animal reference, which scales to roughly 200 to 500 mcg/day in humans. The most common starting protocol is 250 mcg twice daily. No official human dosing standard exists, so doses should be set with a physician. BPC-157 is a research peptide and is not FDA-approved.
What is BPC-157?
BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide derived from a protein found in human gastric juice. It has been studied in hundreds of preclinical experiments for tissue repair, gut health, and recovery. Getting the dose right matters: too little may do nothing, while more than needed wastes product without clearly improving results. Animal safety data has not identified a toxic dose, but that does not replace physician guidance.
What is the standard BPC-157 dosage?
The standard research range is 200 to 800 mcg per day. The most common starting point is 250 mcg twice daily, totaling 500 mcg per day. Lower doses suit general wellness, while higher doses are used for active injuries.
| Goal | Daily dose | Frequency | Route | Duration |
|---|---|---|---|---|
| General wellness | 200 to 300 mcg | Once daily | Subcutaneous | 4 to 6 weeks |
| Moderate injury recovery | 300 to 500 mcg | Once or twice daily | Subcutaneous near injury | 4 to 8 weeks |
| Significant tissue repair | 500 to 800 mcg | Twice daily | Subcutaneous near injury | 6 to 12 weeks |
| Gut health | 250 to 500 mcg | Once or twice daily | Oral capsule | 4 to 8 weeks |
| Tendon or ligament | 300 to 500 mcg | Twice daily | Subcutaneous near tendon | 6 to 10 weeks |
These ranges are commonly discussed protocols in physician-supervised peptide therapy, not standardized medical guidelines.
How does BPC-157 dosing work in research?
In the literature, BPC-157 doses are reported in micrograms per kilogram of body weight. The most studied dose in rodent models is 10 mcg/kg, with a studied range of about 1 to 50 mcg/kg. Animal doses do not translate directly to humans. Using the FDA's body-surface-area conversion, a 10 mcg/kg rat dose maps to roughly 1.6 mcg/kg in a human, but most practitioners use higher doses based on clinical experience. This gap is exactly why a physician, not a research paper, should set your dose.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →| Dose (mcg/kg) | Observed effect | Study context |
|---|---|---|
| 1 mcg/kg | Mild protective effects | Gastric ulcer models |
| 10 mcg/kg | Most consistent therapeutic effects | Tendon, gut, muscle, nerve injury models |
| 50 mcg/kg | No added benefit over 10 mcg/kg in most models | High-dose studies |
How do you dose BPC-157 by body weight?
Some physicians adapt the 10 mcg/kg model to body weight. Because that figure comes from rodent research, many start patients at the low end (about 5 mcg/kg or a flat 250 mcg) and adjust over one to two weeks.
| Body weight | Low dose (5 mcg/kg) | Standard (10 mcg/kg) | High (15 mcg/kg) |
|---|---|---|---|
| 140 lbs (64 kg) | ~320 mcg | ~640 mcg | ~960 mcg |
| 180 lbs (82 kg) | ~410 mcg | ~820 mcg | ~1230 mcg |
| 220 lbs (100 kg) | ~500 mcg | ~1000 mcg | ~1500 mcg |
What are the tissue-specific dosing protocols?
Practitioners often tailor dose, route, and injection site to the target tissue.
- Tendon and ligament: 300 to 500 mcg twice daily, subcutaneous near the tendon, 6 to 10 weeks. Peritendinous injection targets tissue with poor blood supply.
- Muscle: 250 to 500 mcg once or twice daily, subcutaneous near the muscle, 4 to 8 weeks.
- Gut: 250 to 500 mcg once or twice daily, oral on an empty stomach, 4 to 8 weeks. BPC-157 is acid-stable, so oral delivery is viable.
- Joint and cartilage: 250 to 500 mcg once or twice daily, subcutaneous near the joint, 8 to 12 weeks.
- Nerve: 300 to 500 mcg once or twice daily, subcutaneous, 8 to 12 weeks. Nerve repair is among the slowest.
How do you dose by administration route?
| Route | Bioavailability | Best for | Convenience |
|---|---|---|---|
| Subcutaneous | High | Musculoskeletal and systemic | Needs injection technique |
| Intramuscular | High | Deep muscle injuries | Needs injection technique |
| Oral (capsule) | Moderate, acid-stable | Gut and GI conditions | Easy |
Subcutaneous is the most common method, with most protocols at 250 to 500 mcg per injection. For local effects, many practitioners inject near the target area. For systemic effects, the abdomen is standard. Oral dosing is preferred for gut conditions and is taken on an empty stomach.
How do you reconstitute BPC-157?
BPC-157 usually comes as a freeze-dried powder that must be reconstituted with bacteriostatic water before use.
- Confirm the amount in the vial (commonly 5 mg or 10 mg).
- Gather BAC water, alcohol swabs, and insulin syringes.
- Wipe both vial tops.
- Draw the desired BAC water volume.
- Let the water run down the inside wall, do not spray onto the powder.
- Swirl gently, do not shake, until clear.
- Refrigerate at 36 to 46 F and use within 28 days.
| Vial size | BAC water added | Concentration | 250 mcg | 500 mcg |
|---|---|---|---|---|
| 5 mg | 2 mL | 2,500 mcg/mL | 0.10 mL (10 units) | 0.20 mL (20 units) |
| 10 mg | 2 mL | 5,000 mcg/mL | 0.05 mL (5 units) | 0.10 mL (10 units) |
Adding 2 mL of BAC water to a 5 mg vial (2,500 mcg/mL) is a popular choice for easy measurement. Never freeze the reconstituted solution, protect it from light, and discard if it turns cloudy or shows particles.
How long should a BPC-157 cycle last?
Most physician-supervised protocols use cycles rather than continuous use: 4 weeks for mild issues, 6 to 8 weeks for moderate injuries or gut healing, and 8 to 12 weeks for severe cases. A 2 to 4 week break follows most cycles. There is no established research on long-term, uninterrupted human use, so cycling is the prudent approach.
Safety considerations
BPC-157 has shown a strong safety profile in animal studies with no toxic dose identified, but dosing should always involve a physician because animal data does not translate directly, individual factors affect response, and product quality varies. Use only pharmaceutical-grade material from a licensed source. BPC-157 should not be used by people who are pregnant or breastfeeding, who have active cancer (it promotes angiogenesis), who are under 18, or who have a known allergy to it.
A note on FormBlends and BPC-157
BPC-157 is not FDA-approved. FormBlends provides compounded semaglutide and tirzepatide for weight management. This guide is educational, and any BPC-157 protocol should be set and supervised by a licensed physician who can tailor the dose and verify product quality.
Frequently asked questions
What is the standard BPC-157 dosage? There is no official standard. Research references 10 mcg/kg in animals, and human practice typically uses 200 to 800 mcg per day. A physician should determine your dose.
How often should I take BPC-157? Once or twice daily. Once daily suits lower doses and general wellness; twice daily is common for active injuries.
Can I take too much BPC-157? Animal studies have not found a toxic dose, but more than needed does not improve results and wastes product.
Should I inject near the injury or in my stomach? For musculoskeletal injuries, inject subcutaneously near the site. For gut issues, oral dosing targets the GI tract. For systemic effects, the abdomen is standard.
How much bacteriostatic water do I add? For a 5 mg vial, 2 mL creates 2,500 mcg/mL, a popular ratio for easy dosing.
Does BPC-157 need refrigeration? Lyophilized powder is stable at room temperature. After reconstitution it must be refrigerated and used within 28 days.
Can I stack BPC-157 with TB-500? That is the most common injury-recovery stack, but any stacking should be designed and supervised by a physician.
Is BPC-157 FDA-approved? No. It is a research peptide and is not FDA-approved for any condition. FormBlends does not sell it.
Sources
- BPC-157 dosage guide 2026 (Peptides Insider): https://peptidesinsider.com/peptides/bpc-157/dosage
- BPC-157 dosage protocols (PeptideWiki): https://peptidewiki.co/guides/dosage-guides/bpc-157-dosage-guide
- BPC-157 dosing, reconstitution, safety 2026: https://www.peptidedosingprotocols.com/protocol/bpc-157
- Sikiric P, et al. Stable gastric pentadecapeptide BPC 157. Curr Pharm Des. 2011;17(16):1612-1632.
- Nair AB, Jacob S. Dose conversion between animals and human. J Basic Clin Pharm. 2016;7(2):27-31.